Quote Originally Posted by Supersub6 View Post
I am close to being confused.
Boris says that he will not interfere with peoples' long term plans for Christmas, following the details given a few weeks ago.
Starmer says that this is bonkers and that Christmas should be cancelled, however, the Labour Mayor of Manchester is saying that restrictions should be lifted.
Meanwhile, our local news was talking to people in Consett who are obviously scared stiff and think that everyone should be confined to their house or, at least locked into the town, until the virus goes away.

Life goes on regardless here in Ashington, in spite of my neighbour's wife being tested as positive and she has lots of other health problems, fortunately, her husband has an attitude of mind similar to myself and is getting on with things to help her along.
Confusing times Boris will be on TV later to make it all absolutely clear. We have to worry about Nicola, seems we can only meet once over the festive season.

More power to Nicolas elbow

Clinical trials kicked off on Wednesday for an 'old school' coronavirus vaccine being developed and manufactured in Scotland, the fifth jab to be tested in the UK.

The Government has already secured 60 million doses of the Covid-19 shot, which is being developed by French biotech Valneva at its facility in Livingston, West Lothian.

Early phase one trials began today in Bristol and, come the new year, will be expanded to three other National Institute for Health Research (NIHR) testing sites in Birmingham, Newcastle and Southampton.

In total some 150 volunteers will be involved in the phase one and two trials in the UK, which aim to identify whether the vaccine produces a safe and effective immune response. The company hopes that the vaccine will be available by the end of next year, if all goes to plan.

Unlike front runners including the Pfizer-BioNTech jab - which is already being rolled out in the UK and won plaudits for its use of state-of-the-art technology - the team behind the Valneva candidate is betting on a traditional “inactivated” vaccine, of the sort being pursued by China.

Experts say that, while slower to produce, such vaccines should provide broader protection - especially in vulnerable groups - and may be less prone to trigger adverse reactions.